Literature DB >> 16873897

Institution/investigator-initiated clinical trials in Canada.

Jan Sedgeworth1, Lidia Derewlany.   

Abstract

Institution/investigator-initiated clinical trials in Canada require adherence to similar regulations and processes required of large pharmaceutical manufacturers. This may require an investigator to file a Clinical Trial Application. This article outlines the responsibilities and actions that are required prior to, during, and after the conduct of an institution/investigator initiated trial.

Mesh:

Year:  2006        PMID: 16873897

Source DB:  PubMed          Journal:  Can J Clin Pharmacol        ISSN: 1198-581X


  2 in total

1.  [Basic principles, planning and implementation of non-commercial clinical trials].

Authors:  R P Finger; C Coch; M Coenen; M Mengel; G Hartmann; F G Holz
Journal:  Ophthalmologe       Date:  2011-01       Impact factor: 1.059

2.  Investigator-initiated pragmatic trials in developing countries--much needed but much ignored.

Authors:  Nusrat Shafiq; Promila Pandhi; Samir Malhotra
Journal:  Br J Clin Pharmacol       Date:  2008-11-03       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.